Dorsey Wright & Associates Mersana Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.65 - $7.86 $16,882 - $23,485
2,988 New
2,988 $17,000
Q4 2020

Jan 28, 2021
SELL
$16.84 - $27.59 $15,896 - $26,044
-944 Closed
0 $0
Q3 2020

Oct 28, 2020
SELL
$16.2 - $25.7 $5,103 - $8,095
-315 Reduced 25.02%
944 $18,000
Q1 2020

Apr 20, 2020
BUY
$4.41 - $9.28 $5,552 - $11,683
1,259 New
1,259 $7,000

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $74.8M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email